Canada markets closed

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
44.24+0.39 (+0.89%)
At close: 04:00PM EDT
43.31 -0.93 (-2.10%)
After hours: 04:05PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts17171919
Avg. Estimate-1.75-1.64-6.45-5.04
Low Estimate-2.04-2.01-8.32-7.05
High Estimate-1.39-1.36-5.23-1.58
Year Ago EPS-2.33-2.25-8.25-6.45
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts16151819
Avg. Estimate116.36M125.25M513.08M642.09M
Low Estimate98.8M120.38M499.73M541.73M
High Estimate124.6M130.1M530.01M920.7M
Year Ago Sales100.5M108.31M434.25M513.08M
Sales Growth (year/est)15.80%15.60%18.20%25.10%
Earnings History2023-03-302023-06-292023-09-292023-12-30
EPS Est.-1.98-2.07-2.08-1.62
EPS Actual-2.33-2.25-2.23-1.52
Difference-0.35-0.18-0.150.1
Surprise %-17.70%-8.70%-7.20%6.20%
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate-1.75-1.64-6.45-5.04
7 Days Ago-1.76-1.64-6.45-4.97
30 Days Ago-1.76-1.63-6.44-4.96
60 Days Ago-1.76-1.63-6.47-4.92
90 Days Ago-1.65-1.58-6.21-4.36
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days1N/A11
Up Last 30 Days1N/A11
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1111
Growth EstimatesRAREIndustrySector(s)S&P 500
Current Qtr.24.90%N/AN/AN/A
Next Qtr.27.10%N/AN/AN/A
Current Year21.80%N/AN/AN/A
Next Year21.90%N/AN/AN/A
Next 5 Years (per annum)8.90%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A